JPM US Growth D (acc) EURH |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | 51.7 | 16.0 | -29.7 | 30.5 | 10.6 | |
+/-Cat | - | - | - | - | - | |
+/-Idx | - | - | - | - | - | |
Category: Other Equity | ||||||
Benchmarks: - |
Key Stats | ||
NAV 03/05/2024 | EUR 30.79 | |
Day Change | 2.60% | |
Morningstar Category™ | Other Equity | |
ISIN | LU0284208971 | |
Fund Size (Mil) 03/05/2024 | USD 3391.23 | |
Share Class Size (Mil) 03/05/2024 | EUR 73.99 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 06/12/2023 | 2.48% |
Investment Objective: JPM US Growth D (acc) EURH |
To provide long-term capital growth by investing primarily in a growth style biased portfolio of US companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Giri Devulapally 20/12/2010 | ||
Joseph Wilson 17/02/2017 | ||
Inception Date 15/03/2007 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell 1000 Growth NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPM US Growth D (acc) EURH | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 9.59 |
NVIDIA Corp | Technology | 7.87 |
Amazon.com Inc | Consumer Cyclical | 7.11 |
Meta Platforms Inc Class A | Communication Services | 6.14 |
Eli Lilly and Co | Healthcare | 5.40 |
Increase Decrease New since last portfolio | ||
JPM US Growth D (acc) EURH |